| Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors (NCT04560439) | City of Hope Medical Center | 2022-06-15 |
| Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors (NCT05452681) | University of Alabama at Birmingham | 2022-06-01 |
| A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment (NCT05243056) | University of Alabama at Birmingham | 2022-06-01 |
| Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer (NCT05319873) | Jonsson Comprehensive Cancer Center | 2022-04-07 |
| Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study (NCT04993313) | OHSU Knight Cancer Institute | 2022-03-18 |
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors (NCT07259304) | University of Southern California | 2021-11-24 |
| An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors (NCT05012176) | Ohio State University Comprehensive Cancer Center | 2021-11-01 |
| Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer (NCT05086731) | Emory University | 2021-10-22 |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel (NCT04862585) | Ohio State University Comprehensive Cancer Center | 2021-10-07 |
| Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors (NCT04290897) | Jonsson Comprehensive Cancer Center | 2021-09-29 |
| Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study (NCT04754412) | M.D. Anderson Cancer Center | 2021-07-23 |
| Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors (NCT04906200) | Ohio State University Comprehensive Cancer Center | 2021-06-28 |
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer (NCT04481113) | OHSU Knight Cancer Institute | 2021-06-07 |
| Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer (NCT04871516) | Rutgers, The State University of New Jersey | 2021-05-18 |
| Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer (NCT05071677) | M.D. Anderson Cancer Center | 2021-05-03 |
| Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer (NCT04705025) | Jonsson Comprehensive Cancer Center | 2021-04-08 |
| Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors (NCT04999826) | Mayo Clinic | 2021-04-01 |
| Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions (NCT04549571) | Alliance for Clinical Trials in Oncology | 2021-02-16 |
| Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy (NCT04927559) | University of Southern California | 2020-12-18 |
| Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer (NCT04205903) | Ohio State University Comprehensive Cancer Center | 2020-12-11 |
| Nipple Aspirate Fluid in Detecting Breast Cancer (NCT03715959) | Ohio State University Comprehensive Cancer Center | 2020-12-10 |
| Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer (NCT05025059) | M.D. Anderson Cancer Center | 2020-12-03 |
| Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM) (NCT04537312) | Ohio State University Comprehensive Cancer Center | 2020-11-17 |
| Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer (NCT04205071) | Ohio State University Comprehensive Cancer Center | 2020-11-01 |
| Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer (NCT04535323) | Mayo Clinic | 2020-09-23 |
| Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer (NCT04249622) | Mayo Clinic | 2020-09-18 |
| RBX7455 Before Surgery for the Treatment of Operable Breast Cancer (NCT04139993) | Mayo Clinic | 2020-08-31 |
| Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand (NCT04876378) | University of California, San Francisco | 2020-05-18 |
| Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer (NCT04294225) | Mayo Clinic | 2020-04-28 |
| CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy (NCT04266249) | ECOG-ACRIN Cancer Research Group | 2020-03-13 |
| Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors (NCT04200482) | Fred Hutchinson Cancer Center | 2020-02-21 |
| Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM) (NCT04866992) | University of Texas Southwestern Medical Center | 2020-02-01 |
| Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer (NCT04081389) | Roswell Park Cancer Institute | 2019-12-06 |
| Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors (NCT03953157) | Jonsson Comprehensive Cancer Center | 2019-10-07 |
| Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy (NCT03872388) | M.D. Anderson Cancer Center | 2019-09-23 |
| Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer (NCT04001829) | ECOG-ACRIN Cancer Research Group | 2019-08-09 |
| Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted (NCT04185311) | Jonsson Comprehensive Cancer Center | 2019-07-10 |
| Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer (NCT04678414) | M.D. Anderson Cancer Center | 2019-04-01 |
| Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors (NCT03751449) | Roswell Park Cancer Institute | 2019-03-25 |
| Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors (NCT04454086) | Ohio State University Comprehensive Cancer Center | 2019-03-06 |
| Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer (NCT03786354) | Ohio State University Comprehensive Cancer Center | 2019-01-09 |
| A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer (NCT04086875) | Thomas Jefferson University | 2018-11-07 |
| Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer (NCT03774472) | M.D. Anderson Cancer Center | 2018-08-20 |
| Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer (NCT03505671) | Wake Forest University Health Sciences | 2018-08-03 |
| Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer (NCT03505736) | Wake Forest University Health Sciences | 2018-06-21 |
| Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer (NCT03518242) | Fred Hutchinson Cancer Center | 2018-06-06 |
| Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors (NCT03523195) | Fred Hutchinson Cancer Center | 2018-04-18 |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer (NCT02876640) | National Cancer Institute (NCI) | 2018-03-16 |
| Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer (NCT03132467) | M.D. Anderson Cancer Center | 2017-06-13 |
| Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer (NCT03106077) | M.D. Anderson Cancer Center | 2017-06-05 |
| Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer (NCT02918474) | M.D. Anderson Cancer Center | 2017-04-28 |
| Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer (NCT01334021) | M.D. Anderson Cancer Center | 2011-05-31 |
| Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors (NCT03708055) | University of Arizona | 2008-07-24 |
| Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer (NCT00507923) | M.D. Anderson Cancer Center | 2006-11-07 |